Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06467331 Not yet recruiting - Cancer Clinical Trials

The Effect of Hippotherapy on The Development of Life Satisfaction, Health Literacy and Healthism Attitude of Young Adults After Cancer Treatment

Start date: August 1, 2024
Phase: N/A
Study type: Interventional

This research aims to evaluate the impact of hippotherapy on life satisfaction, health literacy, and health culture among young adults who have undergone cancer treatment. The study underscores the importance of providing support to patients post-cancer treatment. While the literature extensively supports the use of animal-assisted interventions in nursing care plans and practices, there is a notable absence of studies examining the holistic effects of hippotherapy on cancer survivors, both nationally and globally. Given that nurses play a pivotal role in the prevention, diagnosis, treatment, and rehabilitation stages of all diseases, and strive to enhance patient quality of life through comprehensive care, the findings of this project are expected to not only bolster the visibility and professional efficacy of nurses but also inspire similar future research. The research tools employed will determine how complementary supportive practices influence the life satisfaction, health literacy, and health culture of young adults during critical life-shaping periods. These results could provide significant evidence of the nurse's role in patient education, support, and overall care improvement.

NCT ID: NCT06465771 Not yet recruiting - Cancer Clinical Trials

Feasibility of a Youth-led NCD Risk Reduction Initiative in Selected Schools of Slums in Karachi, Pakistan: a Mixed-methods, pre-and Post-intervention Study

Start date: August 2024
Phase: N/A
Study type: Interventional

The study will occur in ten selected schools within Azam Basti and Mehmoodabad, organized into five sequential phases. Phase I involves identifying NCD modifiable risk factors among younger peers (Classes 5 and 6 students) using structured diaries. Phase II includes qualitative interviews with youth (Classes 9 and 10 students), parents, and stakeholders to discuss intervention material and delivery. Phase III comprises a one-day workshop to co-create an intervention. Phase IV involves three-day training for youth to understand and deliver the intervention to their peers. Finally, Phase V assesses the intervention's feasibility using a pre-and post-test design approach.

NCT ID: NCT06465511 Not yet recruiting - Cancer Clinical Trials

Supportive Clinic for Patients Living With Advanced and Metastatic Cancers

Start date: August 1, 2024
Phase: N/A
Study type: Interventional

To conduct a feasibility trial to examine the feasibility and acceptability of conducting a randomized controlled trial that evaluates the effect of the survivorship care intervention on patient-reported outcomes, defined as symptom distress and health-related quality of life.

NCT ID: NCT06464471 Not yet recruiting - Cancer Clinical Trials

Comprehensive Health Assessment for My Plan: Initial Implementation Study (CHAMP Implementation Study)

Start date: August 1, 2024
Phase: N/A
Study type: Interventional

The current standard preoperative assessment does not consider the needs of older adults undergoing non-oncological surgery. To enhance the treatment decision-making and planning for older adult surgical patients, the British Geriatric Society and the American Society of Colon and Rectal Surgeons recommend the implementation of preoperative GA for all older adults. Geriatric assessment (GA) predicts treatment toxicity and overall mortality in older adults with complex health problems. However, in-person GA may not be feasible in several clinical settings for various reasons, including lack of training, time, or access to advanced geriatric services. These challenges can be minimized through a self-reported online GA that can be completed by patients prior to the participants' medical appointment. In a previous study, the investigators developed a self-reported online GA, known as the Comprehensive Health Assessment for My Cancer treatment Plan (CHAMP), which was used in geriatric oncology to increase accessibility to GA for older adults with cancer. In this study, the aim is to deploy the CHAMP tool to various clinics across 4 institutions and assess feasibility outcomes, as well as the efficacy of the CHAMP tool in the identification of geriatric issues and the development of supportive care.

NCT ID: NCT06464237 Not yet recruiting - Cancer Clinical Trials

Metacognitive Intervention in Youth With Oncological Disease - the Mio Study

Mio
Start date: November 1, 2024
Phase: N/A
Study type: Interventional

The aim of the Mio-Study is to address the current lack of effective treatment options to reduce cognitive and physical long-term problems in adolescents with cancer. Through the use of the Mio-App, cognitive and physical development will be strengthened and metacognitive thinking and awareness will increase. The Mio-App for adolescence with cancer will include a combination of cognitive and physical training tasks and prospective as well as retrospective metacognitive questions. In a randomized controlled trial, the App will be analysed for its efficacy on metacognitive thinking and executive functions. In particular, the investigators are interested in factors that affect the efficacy of the training program such as compliance, age, sex or the presence of fatigue. This study will give insight into the role of metacognition in cognitive and physical performance and will foster the development of adolescents with cancer in the long-term.

NCT ID: NCT06458036 Not yet recruiting - Cancer Clinical Trials

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

RAISE
Start date: August 1, 2024
Phase: Phase 2
Study type: Interventional

Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve a complete response to RAI therapy, and this therapy carries the risk of pulmonary fibrosis and an increasingly recognized risk of secondary malignancies.

NCT ID: NCT06451003 Not yet recruiting - Cancer Clinical Trials

Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

While blood clots after major cancer surgery are common and harmful to patients, the medications to decrease blood clot risk are seldom used after patients leave the hospital despite the recommendation of multiple professional medical societies. The reason why these medications are seldom prescribed is not well understood. The main questions this study aims to answer are: - Does surgeon education paired with an electronic medical record based decision support tool improve the guideline concordant prescription of pharmacologic venous thromboembolism after abdominopelvic cancer surgery? - Does dedicated patient education regarding blood clots at the time of hospital discharge after abdominopelvic cancer surgery improve understanding of the risk of venous thromboembolism and adherence to pharmacologic prophylaxis? The investigators will study these questions using a stepped-wedge randomized trial where groups of surgeons will use a tool integrated to the electronic medical record to educate them on the individualized patient risks of blood clots after major cancer surgery and inform them regarding guidelines for preventative medicines. Utilization of the medications before and after using the tool will be compared. Patients will be administered a questionnaire assessing their awareness of blood clots as a risk after cancer surgery. For those prescribed medications to reduce blood clot risk after leaving the hospital, the questionnaire will evaluate whether they took the medications as prescribed. Survey results will be evaluated before and after implementation of education on blood clot risk at the time of hospital discharge.

NCT ID: NCT06446115 Not yet recruiting - Cancer Clinical Trials

Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With Cancer

Start date: November 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn if the use of virtual reality during chemotherapy treatment helps participants achieve an improvement in distress, which may include unpleasant experience, anxiety, depression and/or pain. Participants will: - Be randomly assigned to one of two available groups (virtual reality or standard of care) - Participations will only be during one chemotherapy session. - Those assigned to virtual reality: - The research team will provide a virtual reality - The research team will provide guidance on how the headset works and will be available to assist with any questions or concerns. - Participants will also be able to choose different relaxing backgrounds depending on their preference. headset during the chemotherapy session for 15 to 30 minutes - Those assigned to the standard of care: - The research team will provide the participants with the opportunity to choose a preferred activity such as reading a book, watching television, etc.

NCT ID: NCT06445140 Not yet recruiting - Cancer Clinical Trials

Dynamics of Motivational Factors for Physical Activity and Nutrition in Oncogeriatrics

MONAGE
Start date: May 28, 2024
Phase: N/A
Study type: Interventional

Oncogeriatric: a collaboration between oncologists and geriatricians which aims to ensure that all elderly cancer patients receive treatment adapted to their condition, thanks to a multidisciplinary and multi-professional approach. This project aims to gain a better understanding of the motivational determinants of PA and nutrition in elderly cancer patients. It has a dual objective: 1. to identify clusters/groups in patients on the basis of daily motivational factors focusing on PA and nutrition 2. on the basis of the results obtained in (1), to propose an interventional study based on the previously established clusters, in order to examine the effects of a behavioral intervention on patients' adherence to PA and nutrition, both agreed according to an individualized goal and defined in agreement with the patient and the multidisciplinary team, taking into account the recommendations.

NCT ID: NCT06444477 Not yet recruiting - Cancer Clinical Trials

Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer

MATAC
Start date: June 2024
Phase:
Study type: Observational

The association between hematologic malignancies and ITP is well described, but this link is much less clear with solid cancers. In cases of ITP associated with cancers, specific cancer treatment can lead to remission or even cure of ITP. Thus, our hypothesis was that chronic expression of GPIIB by tumor cells could have initiated an autoimmune loop against GPIIB, leading to the onset and perpetuation of ITP.